Table 1.
Gene | Genomic Location/Size | Coding Sequence Size (bp) | Clinical Manifestation | UV-Sensitivity | Residual DNA Repair | Relative Frequency | Skin Cancer | Neurological Implications |
---|---|---|---|---|---|---|---|---|
Global Genome Repair | ||||||||
XPC | 3p25 | 3558 | XP | ++ | <10%–30% | High | + | − |
DDB1 | 11q12–q13 | 3420 | N/A | N/A | N/A | N/A | N/A | N/A |
DDB2 (XPE) | 11p12–p11 | 4193 | XP | + | 50% | Rare | + | − |
Transcription Coupled Repair | ||||||||
CSA | 5q12.1 | 2011 | CS | + | Normal | Intermediate | − | ++ |
CSB | 10q11.21 | 4714 | CS | + | Normal | High | − | ++ |
Nucleotide Excision Repair | ||||||||
XPA | 9q22.3 | 1377 | XP | +++ | <5% | High | + | ++ |
XPB | 2q14.3 | 2751 | XP, XP/CS, TTD | ++ | 3%–40% | Rare | +/− | + |
XPD | 19q13.3 | 2400 | XP, XP/CS, TTD | ++ | 15%–50% | Intermediate | + | ++/− |
XPF | 16p13.1 | 2881 | XP | + | 15%–30% | Rare | + | −/+ |
XPG | 13q33.1 | 4091 | XP, XP/CS | ++ | <5%–30% | Rare | + | ++ |
ERCC1 | 19q13.3–q13.2 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TTD-A | 6p25.3 | 7503 | TTD | N/A | Rare | − | ++ | |
Translesion Synthesis | ||||||||
DN/A PolH (XPV) | 6p21.1 | 2140 | XP | − | Normal | High | +/− | − |
XP: Xeroderma Pigmentosum; CS, Cockayne’s syndrome; TTD: trichothyodystrophy; N/A = not applicable, + = mild, ++ = moderate, +++ = severe and − = not present.